Alchimie S.A.S.

As of December 31, 2024, Alchimie S.A.S. has 4.47M shares outstanding.

These figures are as of December 31, 2024. The price-to-sales ratio is 1.02, and the price-to-book ratio stands at 0.61.

These figures are as of December 31, 2024. The EV/Sales ratio of 4.16 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative.

As of December 31, 2024, Alchimie S.A.S. maintains a current ratio of 0.56, meaning it holds 0.6x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -138.14, indicating conservative leverage, while an interest coverage ratio of -19.02 demonstrates limited ability to service its debt obligations.

Over the twelve months ended December 31, 2024, Alchimie S.A.S. posted a negative return on equity (ROE) of -70.11, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -16.16, reflecting losses generated across the asset base.

As of the close on July 24, 2025, Alchimie S.A.S.'s stock has declined approximately 85.71% over the past 52 weeks. The 50-day moving average sits at 0.11, while the 200-day moving average is 0.27.

Over the twelve months ended December 31, 2024, Alchimie S.A.S. posted a gross margin of 43.70, reflecting its pricing power and cost economics. The operating margin of -340.11 and net profit margin of -115.74 provide insight into operational efficiency.

These figures cover the twelve months ended December 31, 2024. Free cash flow yield is negative at -220.41: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield reaches 7.25, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Alchimie S.A.S. shareholders.

As of December 31, 2024, Alchimie S.A.S. has an Altman Z-Score of -3.06, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.